nodes	percent_of_prediction	percent_of_DWPC	metapath
Sulindac—ALB—type 1 diabetes mellitus	0.458	1	CbGaD
Sulindac—AKR1B1—sciatic nerve—type 1 diabetes mellitus	0.0462	0.32	CbGeAlD
Sulindac—AKR1B1—peripheral nervous system—type 1 diabetes mellitus	0.0177	0.123	CbGeAlD
Sulindac—AKR1B1—islet of Langerhans—type 1 diabetes mellitus	0.00669	0.0464	CbGeAlD
Sulindac—AKR1B1—retina—type 1 diabetes mellitus	0.00572	0.0397	CbGeAlD
Sulindac—AKR1B1—nephron tubule—type 1 diabetes mellitus	0.00539	0.0374	CbGeAlD
Sulindac—PPARD—islet of Langerhans—type 1 diabetes mellitus	0.00526	0.0365	CbGeAlD
Sulindac—AKR1B1—cardiovascular system—type 1 diabetes mellitus	0.00484	0.0336	CbGeAlD
Sulindac—AKR1B1—kidney—type 1 diabetes mellitus	0.00473	0.0328	CbGeAlD
Sulindac—AKR1B1—pancreas—type 1 diabetes mellitus	0.0047	0.0326	CbGeAlD
Sulindac—Bone marrow depression—Ramipril—type 1 diabetes mellitus	0.00418	0.0327	CcSEcCtD
Sulindac—MAPK3—retina—type 1 diabetes mellitus	0.00415	0.0288	CbGeAlD
Sulindac—AKR1B1—lymphoid tissue—type 1 diabetes mellitus	0.00407	0.0282	CbGeAlD
Sulindac—MAPK3—nephron tubule—type 1 diabetes mellitus	0.0039	0.0271	CbGeAlD
Sulindac—PPARD—pancreas—type 1 diabetes mellitus	0.0037	0.0256	CbGeAlD
Sulindac—MAPK3—cardiovascular system—type 1 diabetes mellitus	0.00351	0.0243	CbGeAlD
Sulindac—Ageusia—Ramipril—type 1 diabetes mellitus	0.00348	0.0273	CcSEcCtD
Sulindac—MAPK3—kidney—type 1 diabetes mellitus	0.00343	0.0238	CbGeAlD
Sulindac—MAPK3—pancreas—type 1 diabetes mellitus	0.00341	0.0236	CbGeAlD
Sulindac—Proteinuria—Ramipril—type 1 diabetes mellitus	0.00321	0.0251	CcSEcCtD
Sulindac—PPARD—lymphoid tissue—type 1 diabetes mellitus	0.0032	0.0222	CbGeAlD
Sulindac—Protein urine present—Ramipril—type 1 diabetes mellitus	0.00316	0.0248	CcSEcCtD
Sulindac—Glossitis—Ramipril—type 1 diabetes mellitus	0.00306	0.024	CcSEcCtD
Sulindac—Leukocytosis—Ramipril—type 1 diabetes mellitus	0.003	0.0235	CcSEcCtD
Sulindac—SLC22A6—nephron tubule—type 1 diabetes mellitus	0.00299	0.0207	CbGeAlD
Sulindac—Hearing impaired—Ramipril—type 1 diabetes mellitus	0.00296	0.0232	CcSEcCtD
Sulindac—MAPK3—lymphoid tissue—type 1 diabetes mellitus	0.00295	0.0204	CbGeAlD
Sulindac—Gynaecomastia—Ramipril—type 1 diabetes mellitus	0.00252	0.0198	CcSEcCtD
Sulindac—Photosensitivity—Ramipril—type 1 diabetes mellitus	0.00233	0.0183	CcSEcCtD
Sulindac—Gastroenteritis—Ramipril—type 1 diabetes mellitus	0.00231	0.0181	CcSEcCtD
Sulindac—Vascular purpura—Ramipril—type 1 diabetes mellitus	0.00229	0.0179	CcSEcCtD
Sulindac—Hepatic failure—Ramipril—type 1 diabetes mellitus	0.00228	0.0178	CcSEcCtD
Sulindac—Haemolytic anaemia—Ramipril—type 1 diabetes mellitus	0.00227	0.0178	CcSEcCtD
Sulindac—Dermatitis exfoliative—Ramipril—type 1 diabetes mellitus	0.00217	0.017	CcSEcCtD
Sulindac—Renal impairment—Ramipril—type 1 diabetes mellitus	0.00215	0.0168	CcSEcCtD
Sulindac—Purpura—Ramipril—type 1 diabetes mellitus	0.00212	0.0166	CcSEcCtD
Sulindac—Arthritis—Ramipril—type 1 diabetes mellitus	0.00211	0.0165	CcSEcCtD
Sulindac—Toxic epidermal necrolysis—Ramipril—type 1 diabetes mellitus	0.00184	0.0144	CcSEcCtD
Sulindac—Gastritis—Ramipril—type 1 diabetes mellitus	0.00181	0.0142	CcSEcCtD
Sulindac—Eosinophilia—Ramipril—type 1 diabetes mellitus	0.00175	0.0137	CcSEcCtD
Sulindac—Bronchospasm—Ramipril—type 1 diabetes mellitus	0.00174	0.0136	CcSEcCtD
Sulindac—Pancreatitis—Ramipril—type 1 diabetes mellitus	0.00173	0.0136	CcSEcCtD
Sulindac—Sweating increased—Ramipril—type 1 diabetes mellitus	0.00172	0.0135	CcSEcCtD
Sulindac—Pancytopenia—Ramipril—type 1 diabetes mellitus	0.00168	0.0132	CcSEcCtD
Sulindac—Neutropenia—Ramipril—type 1 diabetes mellitus	0.00165	0.013	CcSEcCtD
Sulindac—Photosensitivity reaction—Ramipril—type 1 diabetes mellitus	0.00161	0.0126	CcSEcCtD
Sulindac—Stevens-Johnson syndrome—Ramipril—type 1 diabetes mellitus	0.00156	0.0122	CcSEcCtD
Sulindac—Renal failure—Ramipril—type 1 diabetes mellitus	0.00155	0.0121	CcSEcCtD
Sulindac—Neuropathy peripheral—Ramipril—type 1 diabetes mellitus	0.00155	0.0121	CcSEcCtD
Sulindac—Stomatitis—Ramipril—type 1 diabetes mellitus	0.00154	0.012	CcSEcCtD
Sulindac—Jaundice—Ramipril—type 1 diabetes mellitus	0.00154	0.012	CcSEcCtD
Sulindac—Conjunctivitis—Ramipril—type 1 diabetes mellitus	0.00153	0.012	CcSEcCtD
Sulindac—Sweating—Ramipril—type 1 diabetes mellitus	0.00151	0.0118	CcSEcCtD
Sulindac—Epistaxis—Ramipril—type 1 diabetes mellitus	0.00149	0.0117	CcSEcCtD
Sulindac—Agranulocytosis—Ramipril—type 1 diabetes mellitus	0.00147	0.0115	CcSEcCtD
Sulindac—Hepatitis—Ramipril—type 1 diabetes mellitus	0.00142	0.0111	CcSEcCtD
Sulindac—Visual impairment—Ramipril—type 1 diabetes mellitus	0.00136	0.0107	CcSEcCtD
Sulindac—Erythema multiforme—Ramipril—type 1 diabetes mellitus	0.00134	0.0105	CcSEcCtD
Sulindac—Tinnitus—Ramipril—type 1 diabetes mellitus	0.00132	0.0103	CcSEcCtD
Sulindac—Flushing—Ramipril—type 1 diabetes mellitus	0.00131	0.0103	CcSEcCtD
Sulindac—Arrhythmia—Ramipril—type 1 diabetes mellitus	0.00126	0.00991	CcSEcCtD
Sulindac—PTGS2—islet of Langerhans—type 1 diabetes mellitus	0.00126	0.00874	CbGeAlD
Sulindac—Alopecia—Ramipril—type 1 diabetes mellitus	0.00125	0.0098	CcSEcCtD
Sulindac—Tension—Ramipril—type 1 diabetes mellitus	0.00121	0.00947	CcSEcCtD
Sulindac—Dysgeusia—Ramipril—type 1 diabetes mellitus	0.00121	0.00946	CcSEcCtD
Sulindac—Nervousness—Ramipril—type 1 diabetes mellitus	0.0012	0.00938	CcSEcCtD
Sulindac—Ill-defined disorder—Ramipril—type 1 diabetes mellitus	0.00114	0.00896	CcSEcCtD
Sulindac—Angioedema—Ramipril—type 1 diabetes mellitus	0.00113	0.00882	CcSEcCtD
Sulindac—Malaise—Ramipril—type 1 diabetes mellitus	0.00111	0.00871	CcSEcCtD
Sulindac—Vertigo—Ramipril—type 1 diabetes mellitus	0.00111	0.00867	CcSEcCtD
Sulindac—Syncope—Ramipril—type 1 diabetes mellitus	0.00111	0.00866	CcSEcCtD
Sulindac—Leukopenia—Ramipril—type 1 diabetes mellitus	0.0011	0.00864	CcSEcCtD
Sulindac—Palpitations—Ramipril—type 1 diabetes mellitus	0.00109	0.00853	CcSEcCtD
Sulindac—Loss of consciousness—Ramipril—type 1 diabetes mellitus	0.00108	0.00849	CcSEcCtD
Sulindac—Convulsion—Ramipril—type 1 diabetes mellitus	0.00107	0.00837	CcSEcCtD
Sulindac—CYP1A1—kidney—type 1 diabetes mellitus	0.00106	0.00736	CbGeAlD
Sulindac—Myalgia—Ramipril—type 1 diabetes mellitus	0.00105	0.00822	CcSEcCtD
Sulindac—Arthralgia—Ramipril—type 1 diabetes mellitus	0.00105	0.00822	CcSEcCtD
Sulindac—Chest pain—Ramipril—type 1 diabetes mellitus	0.00105	0.00822	CcSEcCtD
Sulindac—Discomfort—Ramipril—type 1 diabetes mellitus	0.00104	0.00812	CcSEcCtD
Sulindac—Oedema—Ramipril—type 1 diabetes mellitus	0.00101	0.00788	CcSEcCtD
Sulindac—Anaphylactic shock—Ramipril—type 1 diabetes mellitus	0.00101	0.00788	CcSEcCtD
Sulindac—Shock—Ramipril—type 1 diabetes mellitus	0.00099	0.00775	CcSEcCtD
Sulindac—Thrombocytopenia—Ramipril—type 1 diabetes mellitus	0.000985	0.00772	CcSEcCtD
Sulindac—Tachycardia—Ramipril—type 1 diabetes mellitus	0.000982	0.00769	CcSEcCtD
Sulindac—Hyperhidrosis—Ramipril—type 1 diabetes mellitus	0.000972	0.00762	CcSEcCtD
Sulindac—Anorexia—Ramipril—type 1 diabetes mellitus	0.000959	0.00751	CcSEcCtD
Sulindac—PTGS1—cardiovascular system—type 1 diabetes mellitus	0.000953	0.00661	CbGeAlD
Sulindac—Hypotension—Ramipril—type 1 diabetes mellitus	0.00094	0.00736	CcSEcCtD
Sulindac—PTGS1—kidney—type 1 diabetes mellitus	0.000932	0.00647	CbGeAlD
Sulindac—Musculoskeletal discomfort—Ramipril—type 1 diabetes mellitus	0.000916	0.00718	CcSEcCtD
Sulindac—PTGS2—cardiovascular system—type 1 diabetes mellitus	0.000911	0.00632	CbGeAlD
Sulindac—Insomnia—Ramipril—type 1 diabetes mellitus	0.00091	0.00713	CcSEcCtD
Sulindac—Paraesthesia—Ramipril—type 1 diabetes mellitus	0.000903	0.00708	CcSEcCtD
Sulindac—Dyspnoea—Ramipril—type 1 diabetes mellitus	0.000897	0.00703	CcSEcCtD
Sulindac—Somnolence—Ramipril—type 1 diabetes mellitus	0.000894	0.00701	CcSEcCtD
Sulindac—PTGS2—kidney—type 1 diabetes mellitus	0.000891	0.00618	CbGeAlD
Sulindac—Dyspepsia—Ramipril—type 1 diabetes mellitus	0.000885	0.00694	CcSEcCtD
Sulindac—PTGS2—pancreas—type 1 diabetes mellitus	0.000885	0.00614	CbGeAlD
Sulindac—Decreased appetite—Ramipril—type 1 diabetes mellitus	0.000874	0.00685	CcSEcCtD
Sulindac—Fatigue—Ramipril—type 1 diabetes mellitus	0.000867	0.00679	CcSEcCtD
Sulindac—Constipation—Ramipril—type 1 diabetes mellitus	0.00086	0.00674	CcSEcCtD
Sulindac—Feeling abnormal—Ramipril—type 1 diabetes mellitus	0.000829	0.00649	CcSEcCtD
Sulindac—Gastrointestinal pain—Ramipril—type 1 diabetes mellitus	0.000823	0.00644	CcSEcCtD
Sulindac—Urticaria—Ramipril—type 1 diabetes mellitus	0.000799	0.00626	CcSEcCtD
Sulindac—Body temperature increased—Ramipril—type 1 diabetes mellitus	0.000795	0.00623	CcSEcCtD
Sulindac—PTGS2—lymphoid tissue—type 1 diabetes mellitus	0.000765	0.00531	CbGeAlD
Sulindac—Hypersensitivity—Ramipril—type 1 diabetes mellitus	0.000741	0.00581	CcSEcCtD
Sulindac—Asthenia—Ramipril—type 1 diabetes mellitus	0.000722	0.00565	CcSEcCtD
Sulindac—Pruritus—Ramipril—type 1 diabetes mellitus	0.000712	0.00558	CcSEcCtD
Sulindac—Diarrhoea—Ramipril—type 1 diabetes mellitus	0.000688	0.00539	CcSEcCtD
Sulindac—Dizziness—Ramipril—type 1 diabetes mellitus	0.000665	0.00521	CcSEcCtD
Sulindac—Vomiting—Ramipril—type 1 diabetes mellitus	0.00064	0.00501	CcSEcCtD
Sulindac—Rash—Ramipril—type 1 diabetes mellitus	0.000634	0.00497	CcSEcCtD
Sulindac—Dermatitis—Ramipril—type 1 diabetes mellitus	0.000634	0.00496	CcSEcCtD
Sulindac—Headache—Ramipril—type 1 diabetes mellitus	0.00063	0.00494	CcSEcCtD
Sulindac—Nausea—Ramipril—type 1 diabetes mellitus	0.000597	0.00468	CcSEcCtD
Sulindac—MAPK3—Disease—APOC3—type 1 diabetes mellitus	5.69e-05	0.000211	CbGpPWpGaD
Sulindac—ALB—Hemostasis—SH2B3—type 1 diabetes mellitus	5.69e-05	0.000211	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism of lipids and lipoproteins—APOC3—type 1 diabetes mellitus	5.65e-05	0.000209	CbGpPWpGaD
Sulindac—MAPK3—Downstream signal transduction—IL6—type 1 diabetes mellitus	5.65e-05	0.000209	CbGpPWpGaD
Sulindac—MAPK3—Hemostasis—NOS2—type 1 diabetes mellitus	5.64e-05	0.000209	CbGpPWpGaD
Sulindac—MAPK3—Signaling by FGFR—IL6—type 1 diabetes mellitus	5.62e-05	0.000208	CbGpPWpGaD
Sulindac—PTGS2—Spinal Cord Injury—EGFR—type 1 diabetes mellitus	5.6e-05	0.000208	CbGpPWpGaD
Sulindac—MAPK3—Signaling by ERBB2—IL6—type 1 diabetes mellitus	5.59e-05	0.000207	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—HBA2—type 1 diabetes mellitus	5.57e-05	0.000206	CbGpPWpGaD
Sulindac—MAPK3—Innate Immune System—CRP—type 1 diabetes mellitus	5.57e-05	0.000206	CbGpPWpGaD
Sulindac—MAPK3—DAP12 signaling—IL6—type 1 diabetes mellitus	5.56e-05	0.000206	CbGpPWpGaD
Sulindac—ALB—Folate Metabolism—IL6—type 1 diabetes mellitus	5.55e-05	0.000205	CbGpPWpGaD
Sulindac—ALB—Transmembrane transport of small molecules—CP—type 1 diabetes mellitus	5.53e-05	0.000205	CbGpPWpGaD
Sulindac—ALB—Transmembrane transport of small molecules—SLC11A1—type 1 diabetes mellitus	5.48e-05	0.000203	CbGpPWpGaD
Sulindac—MAPK3—Cell Cycle—CDK4—type 1 diabetes mellitus	5.48e-05	0.000203	CbGpPWpGaD
Sulindac—MAPK3—Disease—B2M—type 1 diabetes mellitus	5.46e-05	0.000202	CbGpPWpGaD
Sulindac—ALB—Selenium Micronutrient Network—TNF—type 1 diabetes mellitus	5.46e-05	0.000202	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—TYK2—type 1 diabetes mellitus	5.46e-05	0.000202	CbGpPWpGaD
Sulindac—PTGS2—Selenium Micronutrient Network—IL6—type 1 diabetes mellitus	5.45e-05	0.000202	CbGpPWpGaD
Sulindac—MAPK3—Cellular responses to stress—STAT3—type 1 diabetes mellitus	5.44e-05	0.000202	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—NOS3—type 1 diabetes mellitus	5.36e-05	0.000198	CbGpPWpGaD
Sulindac—PTGS2—Spinal Cord Injury—TNF—type 1 diabetes mellitus	5.34e-05	0.000198	CbGpPWpGaD
Sulindac—MAPK3—Signaling by GPCR—GCG—type 1 diabetes mellitus	5.28e-05	0.000196	CbGpPWpGaD
Sulindac—MAPK3—Developmental Biology—INS—type 1 diabetes mellitus	5.27e-05	0.000195	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—G6PC2—type 1 diabetes mellitus	5.24e-05	0.000194	CbGpPWpGaD
Sulindac—MAPK3—Signaling by FGFR in disease—IL6—type 1 diabetes mellitus	5.24e-05	0.000194	CbGpPWpGaD
Sulindac—MAPK3—DAP12 interactions—IL6—type 1 diabetes mellitus	5.24e-05	0.000194	CbGpPWpGaD
Sulindac—MAPK3—Fc epsilon receptor (FCERI) signaling—IL6—type 1 diabetes mellitus	5.24e-05	0.000194	CbGpPWpGaD
Sulindac—MAPK3—Immune System—HLA-DPB1—type 1 diabetes mellitus	5.23e-05	0.000194	CbGpPWpGaD
Sulindac—MAPK3—Cytokine Signaling in Immune system—STAT3—type 1 diabetes mellitus	5.19e-05	0.000192	CbGpPWpGaD
Sulindac—MAPK3—Signaling by EGFR—IL6—type 1 diabetes mellitus	5.19e-05	0.000192	CbGpPWpGaD
Sulindac—ALB—Metabolism of lipids and lipoproteins—APOC3—type 1 diabetes mellitus	5.15e-05	0.000191	CbGpPWpGaD
Sulindac—MAPK3—Immune System—HLA-E—type 1 diabetes mellitus	5.15e-05	0.000191	CbGpPWpGaD
Sulindac—MAPK3—Signaling by EGFR in Cancer—IL6—type 1 diabetes mellitus	5.14e-05	0.00019	CbGpPWpGaD
Sulindac—MAPK3—Signaling by PDGF—IL6—type 1 diabetes mellitus	5.12e-05	0.00019	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—GAL—type 1 diabetes mellitus	5.11e-05	0.000189	CbGpPWpGaD
Sulindac—MAPK3—Signaling by NGF—STAT3—type 1 diabetes mellitus	5.11e-05	0.000189	CbGpPWpGaD
Sulindac—MAPK3—Signaling by GPCR—PRKCQ—type 1 diabetes mellitus	5.08e-05	0.000188	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—CCL11—type 1 diabetes mellitus	5.05e-05	0.000187	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—CCL20—type 1 diabetes mellitus	5.05e-05	0.000187	CbGpPWpGaD
Sulindac—MAPK3—Cellular Senescence—IL6—type 1 diabetes mellitus	5.03e-05	0.000186	CbGpPWpGaD
Sulindac—MAPK3—Hemostasis—IGF1—type 1 diabetes mellitus	5e-05	0.000185	CbGpPWpGaD
Sulindac—PTGS2—Integrated Pancreatic Cancer Pathway—CASP3—type 1 diabetes mellitus	4.99e-05	0.000185	CbGpPWpGaD
Sulindac—MAPK3—Immune System—CTLA4—type 1 diabetes mellitus	4.96e-05	0.000184	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—HBA2—type 1 diabetes mellitus	4.95e-05	0.000183	CbGpPWpGaD
Sulindac—MAPK3—Signaling by GPCR—VAV1—type 1 diabetes mellitus	4.94e-05	0.000183	CbGpPWpGaD
Sulindac—MAPK3—Innate Immune System—CD80—type 1 diabetes mellitus	4.93e-05	0.000182	CbGpPWpGaD
Sulindac—MAPK3—Signaling by GPCR—CXCL10—type 1 diabetes mellitus	4.92e-05	0.000182	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—CHRM2—type 1 diabetes mellitus	4.75e-05	0.000176	CbGpPWpGaD
Sulindac—MAPK3—Hemostasis—ALB—type 1 diabetes mellitus	4.74e-05	0.000176	CbGpPWpGaD
Sulindac—MAPK3—Immune System—CD79A—type 1 diabetes mellitus	4.73e-05	0.000175	CbGpPWpGaD
Sulindac—MAPK3—Developmental Biology—TYK2—type 1 diabetes mellitus	4.71e-05	0.000174	CbGpPWpGaD
Sulindac—ALB—Platelet activation, signaling and aggregation—IGF1—type 1 diabetes mellitus	4.67e-05	0.000173	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—G6PC2—type 1 diabetes mellitus	4.65e-05	0.000172	CbGpPWpGaD
Sulindac—MAPK3—Immune System—PRKCQ—type 1 diabetes mellitus	4.64e-05	0.000172	CbGpPWpGaD
Sulindac—MAPK3—Signaling by NGF—EGFR—type 1 diabetes mellitus	4.64e-05	0.000172	CbGpPWpGaD
Sulindac—MAPK3—NGF signalling via TRKA from the plasma membrane—IL6—type 1 diabetes mellitus	4.64e-05	0.000172	CbGpPWpGaD
Sulindac—MAPK3—Disease—NOS1—type 1 diabetes mellitus	4.58e-05	0.00017	CbGpPWpGaD
Sulindac—ALB—Hemostasis—NOS1—type 1 diabetes mellitus	4.55e-05	0.000169	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—CASP3—type 1 diabetes mellitus	4.55e-05	0.000168	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—ABCC8—type 1 diabetes mellitus	4.54e-05	0.000168	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—IL2—type 1 diabetes mellitus	4.54e-05	0.000168	CbGpPWpGaD
Sulindac—MAPK3—Hemostasis—NOS3—type 1 diabetes mellitus	4.53e-05	0.000168	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—KCNJ11—type 1 diabetes mellitus	4.52e-05	0.000168	CbGpPWpGaD
Sulindac—PTGDR2—Signaling by GPCR—IL6—type 1 diabetes mellitus	4.52e-05	0.000167	CbGpPWpGaD
Sulindac—MAPK3—Immune System—VAV1—type 1 diabetes mellitus	4.51e-05	0.000167	CbGpPWpGaD
Sulindac—ALB—Metabolism—HBA2—type 1 diabetes mellitus	4.51e-05	0.000167	CbGpPWpGaD
Sulindac—MAPK3—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—type 1 diabetes mellitus	4.48e-05	0.000166	CbGpPWpGaD
Sulindac—ALB—Selenium Micronutrient Network—IL6—type 1 diabetes mellitus	4.41e-05	0.000163	CbGpPWpGaD
Sulindac—MAPK3—Immune System—HLA-DQA1—type 1 diabetes mellitus	4.37e-05	0.000162	CbGpPWpGaD
Sulindac—PTGS2—Spinal Cord Injury—IL6—type 1 diabetes mellitus	4.31e-05	0.00016	CbGpPWpGaD
Sulindac—MAPK3—Disease—PRKCQ—type 1 diabetes mellitus	4.29e-05	0.000159	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—ITPR3—type 1 diabetes mellitus	4.26e-05	0.000158	CbGpPWpGaD
Sulindac—ALB—Hemostasis—PRKCQ—type 1 diabetes mellitus	4.26e-05	0.000158	CbGpPWpGaD
Sulindac—ALB—Metabolism—G6PC2—type 1 diabetes mellitus	4.24e-05	0.000157	CbGpPWpGaD
Sulindac—MAPK3—Axon guidance—EGFR—type 1 diabetes mellitus	4.2e-05	0.000156	CbGpPWpGaD
Sulindac—MAPK3—Disease—VAV1—type 1 diabetes mellitus	4.16e-05	0.000154	CbGpPWpGaD
Sulindac—MAPK3—Innate Immune System—TYK2—type 1 diabetes mellitus	4.16e-05	0.000154	CbGpPWpGaD
Sulindac—ALB—Hemostasis—VAV1—type 1 diabetes mellitus	4.14e-05	0.000153	CbGpPWpGaD
Sulindac—PPARD—Metabolism—INS—type 1 diabetes mellitus	4.11e-05	0.000152	CbGpPWpGaD
Sulindac—MAPK3—Immune System—HLA-DQB1—type 1 diabetes mellitus	4.08e-05	0.000151	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—ABCC8—type 1 diabetes mellitus	4.03e-05	0.000149	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—SH2B3—type 1 diabetes mellitus	4.01e-05	0.000149	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—APOC3—type 1 diabetes mellitus	3.99e-05	0.000148	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—IAPP—type 1 diabetes mellitus	3.99e-05	0.000148	CbGpPWpGaD
Sulindac—MAPK3—Gene Expression—VDR—type 1 diabetes mellitus	3.94e-05	0.000146	CbGpPWpGaD
Sulindac—MAPK3—Immune System—CD86—type 1 diabetes mellitus	3.93e-05	0.000146	CbGpPWpGaD
Sulindac—MAPK3—Immune System—CD40LG—type 1 diabetes mellitus	3.86e-05	0.000143	CbGpPWpGaD
Sulindac—MAPK3—Hemostasis—IL2—type 1 diabetes mellitus	3.84e-05	0.000142	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—STAT3—type 1 diabetes mellitus	3.82e-05	0.000142	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—ITPR3—type 1 diabetes mellitus	3.82e-05	0.000141	CbGpPWpGaD
Sulindac—MAPK3—Signaling by GPCR—CCR5—type 1 diabetes mellitus	3.82e-05	0.000141	CbGpPWpGaD
Sulindac—MAPK3—Immune System—CD8A—type 1 diabetes mellitus	3.81e-05	0.000141	CbGpPWpGaD
Sulindac—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—type 1 diabetes mellitus	3.81e-05	0.000141	CbGpPWpGaD
Sulindac—MAPK3—Cellular responses to stress—IL6—type 1 diabetes mellitus	3.8e-05	0.000141	CbGpPWpGaD
Sulindac—SLC22A6—Transmembrane transport of small molecules—ALB—type 1 diabetes mellitus	3.8e-05	0.000141	CbGpPWpGaD
Sulindac—PTGS2—Disease—SLC11A1—type 1 diabetes mellitus	3.79e-05	0.00014	CbGpPWpGaD
Sulindac—PPARD—Metabolism—ALB—type 1 diabetes mellitus	3.76e-05	0.000139	CbGpPWpGaD
Sulindac—MAPK3—Signaling by GPCR—IL2RA—type 1 diabetes mellitus	3.76e-05	0.000139	CbGpPWpGaD
Sulindac—MAPK3—Innate Immune System—CD4—type 1 diabetes mellitus	3.76e-05	0.000139	CbGpPWpGaD
Sulindac—ALB—Hemostasis—IGF2—type 1 diabetes mellitus	3.75e-05	0.000139	CbGpPWpGaD
Sulindac—ALB—Metabolism—ABCC8—type 1 diabetes mellitus	3.68e-05	0.000136	CbGpPWpGaD
Sulindac—MAPK3—Immune System—HLA-B—type 1 diabetes mellitus	3.67e-05	0.000136	CbGpPWpGaD
Sulindac—MAPK3—Disease—CD86—type 1 diabetes mellitus	3.63e-05	0.000135	CbGpPWpGaD
Sulindac—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—type 1 diabetes mellitus	3.63e-05	0.000134	CbGpPWpGaD
Sulindac—MAPK3—Cytokine Signaling in Immune system—IL6—type 1 diabetes mellitus	3.63e-05	0.000134	CbGpPWpGaD
Sulindac—PTGS2—Disease—ITPR3—type 1 diabetes mellitus	3.62e-05	0.000134	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism of lipids and lipoproteins—APOC3—type 1 diabetes mellitus	3.6e-05	0.000133	CbGpPWpGaD
Sulindac—PPARD—Metabolism—NOS3—type 1 diabetes mellitus	3.6e-05	0.000133	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—HBA1—type 1 diabetes mellitus	3.59e-05	0.000133	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—KCNJ11—type 1 diabetes mellitus	3.59e-05	0.000133	CbGpPWpGaD
Sulindac—ALB—Platelet activation, signaling and aggregation—IL2—type 1 diabetes mellitus	3.59e-05	0.000133	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—APOC3—type 1 diabetes mellitus	3.57e-05	0.000132	CbGpPWpGaD
Sulindac—MAPK3—Signaling by NGF—IL6—type 1 diabetes mellitus	3.57e-05	0.000132	CbGpPWpGaD
Sulindac—MAPK3—Immune System—ERBB3—type 1 diabetes mellitus	3.55e-05	0.000131	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—GSTT1—type 1 diabetes mellitus	3.51e-05	0.00013	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—SST—type 1 diabetes mellitus	3.5e-05	0.00013	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—ADRB1—type 1 diabetes mellitus	3.48e-05	0.000129	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—EGFR—type 1 diabetes mellitus	3.47e-05	0.000129	CbGpPWpGaD
Sulindac—MAPK3—Immune System—IL2RA—type 1 diabetes mellitus	3.44e-05	0.000127	CbGpPWpGaD
Sulindac—MAPK3—Immune System—HLA-A—type 1 diabetes mellitus	3.4e-05	0.000126	CbGpPWpGaD
Sulindac—PTGS2—Disease—APOC3—type 1 diabetes mellitus	3.39e-05	0.000125	CbGpPWpGaD
Sulindac—PTGS2—Disease—IAPP—type 1 diabetes mellitus	3.39e-05	0.000125	CbGpPWpGaD
Sulindac—MAPK3—Developmental Biology—STAT3—type 1 diabetes mellitus	3.3e-05	0.000122	CbGpPWpGaD
Sulindac—MAPK3—Disease—ERBB3—type 1 diabetes mellitus	3.27e-05	0.000121	CbGpPWpGaD
Sulindac—PTGS2—Disease—B2M—type 1 diabetes mellitus	3.25e-05	0.00012	CbGpPWpGaD
Sulindac—MAPK3—Immune System—CRP—type 1 diabetes mellitus	3.24e-05	0.00012	CbGpPWpGaD
Sulindac—PTGS1—Metabolism of lipids and lipoproteins—ALB—type 1 diabetes mellitus	3.23e-05	0.00012	CbGpPWpGaD
Sulindac—MAPK3—Axon guidance—IL6—type 1 diabetes mellitus	3.23e-05	0.00012	CbGpPWpGaD
Sulindac—MAPK3—Disease—CCR5—type 1 diabetes mellitus	3.22e-05	0.000119	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—KCNJ11—type 1 diabetes mellitus	3.19e-05	0.000118	CbGpPWpGaD
Sulindac—ALB—Hemostasis—IL2RA—type 1 diabetes mellitus	3.15e-05	0.000117	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—HBA2—type 1 diabetes mellitus	3.15e-05	0.000117	CbGpPWpGaD
Sulindac—MAPK3—Disease—HLA-A—type 1 diabetes mellitus	3.14e-05	0.000116	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—GCG—type 1 diabetes mellitus	3.12e-05	0.000116	CbGpPWpGaD
Sulindac—MAPK3—Immune System—HLA-DRB1—type 1 diabetes mellitus	3.11e-05	0.000115	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—ITPR3—type 1 diabetes mellitus	3.03e-05	0.000112	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—PRKCQ—type 1 diabetes mellitus	3e-05	0.000111	CbGpPWpGaD
Sulindac—MAPK3—Developmental Biology—EGFR—type 1 diabetes mellitus	3e-05	0.000111	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—G6PC2—type 1 diabetes mellitus	2.97e-05	0.00011	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—VAV1—type 1 diabetes mellitus	2.92e-05	0.000108	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—CXCL10—type 1 diabetes mellitus	2.91e-05	0.000108	CbGpPWpGaD
Sulindac—ALB—Metabolism—KCNJ11—type 1 diabetes mellitus	2.91e-05	0.000108	CbGpPWpGaD
Sulindac—MAPK3—Immune System—CD80—type 1 diabetes mellitus	2.87e-05	0.000106	CbGpPWpGaD
Sulindac—MAPK3—Developmental Biology—TNF—type 1 diabetes mellitus	2.85e-05	0.000106	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—HBA1—type 1 diabetes mellitus	2.85e-05	0.000106	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—APOC3—type 1 diabetes mellitus	2.84e-05	0.000105	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—GCG—type 1 diabetes mellitus	2.79e-05	0.000104	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—GSTT1—type 1 diabetes mellitus	2.78e-05	0.000103	CbGpPWpGaD
Sulindac—MAPK3—Disease—NOS2—type 1 diabetes mellitus	2.73e-05	0.000101	CbGpPWpGaD
Sulindac—PTGS2—Disease—NOS1—type 1 diabetes mellitus	2.72e-05	0.000101	CbGpPWpGaD
Sulindac—ALB—Hemostasis—NOS2—type 1 diabetes mellitus	2.71e-05	0.000101	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—ITPR3—type 1 diabetes mellitus	2.69e-05	9.97e-05	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—IL6—type 1 diabetes mellitus	2.67e-05	9.89e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling by GPCR—TYK2—type 1 diabetes mellitus	2.65e-05	9.82e-05	CbGpPWpGaD
Sulindac—MAPK3—Disease—CD80—type 1 diabetes mellitus	2.65e-05	9.81e-05	CbGpPWpGaD
Sulindac—MAPK3—Innate Immune System—EGFR—type 1 diabetes mellitus	2.65e-05	9.8e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—IGF2—type 1 diabetes mellitus	2.64e-05	9.78e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—ABCC8—type 1 diabetes mellitus	2.57e-05	9.52e-05	CbGpPWpGaD
Sulindac—PTGS2—Metabolism of lipids and lipoproteins—ALB—type 1 diabetes mellitus	2.57e-05	9.51e-05	CbGpPWpGaD
Sulindac—PTGS2—Disease—PRKCQ—type 1 diabetes mellitus	2.55e-05	9.45e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—CD86—type 1 diabetes mellitus	2.54e-05	9.42e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—HBA1—type 1 diabetes mellitus	2.53e-05	9.38e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—APOC3—type 1 diabetes mellitus	2.52e-05	9.32e-05	CbGpPWpGaD
Sulindac—MAPK3—Disease—INS—type 1 diabetes mellitus	2.5e-05	9.27e-05	CbGpPWpGaD
Sulindac—PTGS2—Disease—VAV1—type 1 diabetes mellitus	2.48e-05	9.17e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—GSTT1—type 1 diabetes mellitus	2.47e-05	9.15e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism—ITPR3—type 1 diabetes mellitus	2.45e-05	9.08e-05	CbGpPWpGaD
Sulindac—MAPK3—Immune System—TYK2—type 1 diabetes mellitus	2.42e-05	8.97e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—E2F1—type 1 diabetes mellitus	2.41e-05	8.94e-05	CbGpPWpGaD
Sulindac—ALB—Hemostasis—IGF1—type 1 diabetes mellitus	2.41e-05	8.91e-05	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—CAT—type 1 diabetes mellitus	2.37e-05	8.76e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism—HBA1—type 1 diabetes mellitus	2.31e-05	8.55e-05	CbGpPWpGaD
Sulindac—MAPK3—Developmental Biology—IL6—type 1 diabetes mellitus	2.3e-05	8.53e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism—APOC3—type 1 diabetes mellitus	2.29e-05	8.5e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—ERBB3—type 1 diabetes mellitus	2.29e-05	8.49e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism of lipids and lipoproteins—ALB—type 1 diabetes mellitus	2.28e-05	8.44e-05	CbGpPWpGaD
Sulindac—MAPK3—Immune System—IFNG—type 1 diabetes mellitus	2.27e-05	8.4e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—CCR5—type 1 diabetes mellitus	2.26e-05	8.35e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism—GSTT1—type 1 diabetes mellitus	2.25e-05	8.34e-05	CbGpPWpGaD
Sulindac—MAPK3—Disease—TYK2—type 1 diabetes mellitus	2.24e-05	8.28e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—IL2RA—type 1 diabetes mellitus	2.22e-05	8.23e-05	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—GCG—type 1 diabetes mellitus	2.22e-05	8.22e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling by GPCR—IL2—type 1 diabetes mellitus	2.21e-05	8.17e-05	CbGpPWpGaD
Sulindac—MAPK3—Disease—NOS3—type 1 diabetes mellitus	2.2e-05	8.13e-05	CbGpPWpGaD
Sulindac—MAPK3—Immune System—CD4—type 1 diabetes mellitus	2.19e-05	8.11e-05	CbGpPWpGaD
Sulindac—ALB—Hemostasis—NOS3—type 1 diabetes mellitus	2.18e-05	8.08e-05	CbGpPWpGaD
Sulindac—PTGS2—Disease—CD86—type 1 diabetes mellitus	2.16e-05	8e-05	CbGpPWpGaD
Sulindac—MAPK3—Innate Immune System—IL6—type 1 diabetes mellitus	2.03e-05	7.53e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—KCNJ11—type 1 diabetes mellitus	2.03e-05	7.53e-05	CbGpPWpGaD
Sulindac—MAPK3—Immune System—IL1B—type 1 diabetes mellitus	2.02e-05	7.49e-05	CbGpPWpGaD
Sulindac—MAPK3—Disease—CD4—type 1 diabetes mellitus	2.02e-05	7.49e-05	CbGpPWpGaD
Sulindac—MAPK3—Immune System—IL2—type 1 diabetes mellitus	2.02e-05	7.47e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—GCG—type 1 diabetes mellitus	1.97e-05	7.29e-05	CbGpPWpGaD
Sulindac—PTGS2—Disease—ERBB3—type 1 diabetes mellitus	1.95e-05	7.21e-05	CbGpPWpGaD
Sulindac—PTGS2—Disease—CCR5—type 1 diabetes mellitus	1.92e-05	7.09e-05	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—CAT—type 1 diabetes mellitus	1.88e-05	6.96e-05	CbGpPWpGaD
Sulindac—PTGS2—Disease—HLA-A—type 1 diabetes mellitus	1.87e-05	6.91e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—CD80—type 1 diabetes mellitus	1.86e-05	6.87e-05	CbGpPWpGaD
Sulindac—ALB—Hemostasis—IL2—type 1 diabetes mellitus	1.85e-05	6.85e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism—GCG—type 1 diabetes mellitus	1.79e-05	6.65e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—INS—type 1 diabetes mellitus	1.75e-05	6.49e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—ITPR3—type 1 diabetes mellitus	1.72e-05	6.35e-05	CbGpPWpGaD
Sulindac—MAPK3—Immune System—STAT3—type 1 diabetes mellitus	1.7e-05	6.28e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—IGF1—type 1 diabetes mellitus	1.7e-05	6.28e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling by GPCR—EGFR—type 1 diabetes mellitus	1.69e-05	6.25e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—CAT—type 1 diabetes mellitus	1.67e-05	6.17e-05	CbGpPWpGaD
Sulindac—PTGS2—Disease—NOS2—type 1 diabetes mellitus	1.62e-05	6.01e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—HBA1—type 1 diabetes mellitus	1.61e-05	5.98e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—APOC3—type 1 diabetes mellitus	1.6e-05	5.94e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—GSTT1—type 1 diabetes mellitus	1.58e-05	5.84e-05	CbGpPWpGaD
Sulindac—PTGS2—Disease—CD80—type 1 diabetes mellitus	1.58e-05	5.84e-05	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—INS—type 1 diabetes mellitus	1.57e-05	5.82e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—TYK2—type 1 diabetes mellitus	1.57e-05	5.8e-05	CbGpPWpGaD
Sulindac—MAPK3—Disease—STAT3—type 1 diabetes mellitus	1.57e-05	5.8e-05	CbGpPWpGaD
Sulindac—MAPK3—Immune System—EGFR—type 1 diabetes mellitus	1.54e-05	5.71e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—NOS3—type 1 diabetes mellitus	1.54e-05	5.69e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism—CAT—type 1 diabetes mellitus	1.52e-05	5.63e-05	CbGpPWpGaD
Sulindac—PTGS2—Disease—INS—type 1 diabetes mellitus	1.49e-05	5.51e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism of lipids and lipoproteins—ALB—type 1 diabetes mellitus	1.45e-05	5.38e-05	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—ALB—type 1 diabetes mellitus	1.44e-05	5.33e-05	CbGpPWpGaD
Sulindac—MAPK3—Disease—EGFR—type 1 diabetes mellitus	1.42e-05	5.27e-05	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—NOS3—type 1 diabetes mellitus	1.38e-05	5.1e-05	CbGpPWpGaD
Sulindac—PTGS2—Disease—TYK2—type 1 diabetes mellitus	1.33e-05	4.93e-05	CbGpPWpGaD
Sulindac—PTGS2—Disease—NOS3—type 1 diabetes mellitus	1.31e-05	4.84e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—CASP3—type 1 diabetes mellitus	1.31e-05	4.83e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—IL2—type 1 diabetes mellitus	1.3e-05	4.83e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling by GPCR—IL6—type 1 diabetes mellitus	1.3e-05	4.8e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—GCG—type 1 diabetes mellitus	1.26e-05	4.65e-05	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—INS—type 1 diabetes mellitus	1.25e-05	4.62e-05	CbGpPWpGaD
Sulindac—PTGS2—Disease—CD4—type 1 diabetes mellitus	1.2e-05	4.46e-05	CbGpPWpGaD
Sulindac—MAPK3—Immune System—IL6—type 1 diabetes mellitus	1.18e-05	4.39e-05	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—ALB—type 1 diabetes mellitus	1.14e-05	4.23e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—INS—type 1 diabetes mellitus	1.11e-05	4.1e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—STAT3—type 1 diabetes mellitus	1.1e-05	4.06e-05	CbGpPWpGaD
Sulindac—MAPK3—Disease—IL6—type 1 diabetes mellitus	1.09e-05	4.05e-05	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—NOS3—type 1 diabetes mellitus	1.09e-05	4.05e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—CAT—type 1 diabetes mellitus	1.06e-05	3.94e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—ALB—type 1 diabetes mellitus	1.01e-05	3.76e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism—INS—type 1 diabetes mellitus	1.01e-05	3.74e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—EGFR—type 1 diabetes mellitus	9.97e-06	3.69e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—NOS3—type 1 diabetes mellitus	9.7e-06	3.59e-05	CbGpPWpGaD
Sulindac—PTGS2—Disease—STAT3—type 1 diabetes mellitus	9.31e-06	3.45e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism—NOS3—type 1 diabetes mellitus	8.85e-06	3.28e-05	CbGpPWpGaD
Sulindac—PTGS2—Disease—EGFR—type 1 diabetes mellitus	8.46e-06	3.14e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—IL6—type 1 diabetes mellitus	7.66e-06	2.84e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—INS—type 1 diabetes mellitus	7.05e-06	2.61e-05	CbGpPWpGaD
Sulindac—PTGS2—Disease—IL6—type 1 diabetes mellitus	6.5e-06	2.41e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—ALB—type 1 diabetes mellitus	6.47e-06	2.4e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—NOS3—type 1 diabetes mellitus	6.19e-06	2.29e-05	CbGpPWpGaD
